11^th International Conference on Brain Injury & Neuro Surgeons March 20-21, 2023 Berlin, Germany

Sybille Krauß studied biotechnology at the Technische Fachhochschule Berlin until 2002. As graduate student she worked at the Max Planck Institute for Molecular Genetics and received her PhD in 2005 for her thesis „Characterization of microtubule-associated PP2A and their target proteins”. After this, she conducted research as postdoc at the Charité in the group of Prof. Susann Schweiger. Since 2010 Sybille Krauß is groupleader at DZNE in Bonn

Neurodegenerative Diseases

Yuri Danilov, PhD, currently is the Leading Scientist in Pavlov Institute of Physiology, RAS, Sankt Petersburg, Russia. He is a former Senior Scientist and Neuroscience Director in Tactile Communication and Neuromodulation Laboratory (TCNL), Biomedical Engineering Department, UW-Madison, USA. Dr. Danilov received an MS degree in Biophysics, in 1978, from St. Petersburg University in Russia and a Ph.D. degree in neuroscience, in 1984, from the Pavlov Institute of Physiology. He is a system Neuroscientist with experience in research on the special senses, including vision, taste, hearing and balance. Dr. Danilov is the lead discoverer and developer of the Translingual Neurostimulation technology.

Neurology

Kateryna Yatsenko, MD, PhD is a Senior Research Fellow. Yatsenko’s research interest includes Neurology, Disorders of the CNS, transcranial direct current stimulation, intermittent normobaric hypoxia treatment, CItherapy.

Neurology

Kaja is an experienced neurobiologist with a long-standing research track record in academia and the biotech and pharmaceutical industry. Kaja currently serves as Associate Director of Preclinical Research at the Vision Research Center at the University of Missouri - Kansas City, School of Medicine. He is the Director of Microscopy of the imaging core facility at the Vision Research Center and also holds an appointment to Assistant Professor of Ophthalmology. His NIH-funded research program focuses on human neurological and neurodegenerative diseases, visual disorders and inflammation. Kaja obtained his B.Sc. (Hons.) degree in Molecular Biology and Biochemistry from Durham University, UK and holds a Ph.D. degree in Medicine/Neuroscience from Leiden University, The Netherlands. Prior to joining the faculty at the University of Missouri - Kansas City, he has performed postdoctoral work at The University of British Columbia (Vancouver, B.C., Canada) and the University of North Texas Health Science Center (Fort Worth, TX). In addition to his academic work, Dr. Kaja has worked and consulted for a number of pharmaceutical companies, incl. Novo Nordisk A/S, Bayer AG, Neuromed Pharmaceuticals Inc., and NeuroSearch A/S. He is CEO and co-founder of K&P Scientific LLC, a scientific consulting company headquartered in Kansas City, MO.

Pathophysiological mechanisms underlying neurodegenerative, neurological and visual disorders.

Sybille Krauß studied biotechnology at the Technische Fachhochschule Berlin until 2002. As graduate student she worked at the Max Planck Institute for Molecular Genetics and received her PhD in 2005 for her thesis „Characterization of microtubule-associated PP2A and their target proteins”. After this, she conducted research as postdoc at the Charité in the group of Prof. Susann Schweiger. Since 2010 Sybille Krauß is groupleader at DZNE in Bonn.

Neurodegenerative Diseases